J Korean Soc Vasc Surg.  2010 May;26(1):24-29.

Comparison of Mid-term Results of Surgical and Endovascular Treatment for TASC C & D Lesions of the Iliac Artery

Affiliations
  • 1Department of Surgery, Keimyung University School of Medicine, Daegu, Korea. htkim@dsmc.or.kr
  • 2Department of Diagnostic Radiology, Keimyung University School of Medicine, Daegu, Korea.

Abstract

PURPOSE
In order to establish therapeutic guidelines for TASC C & D iliac lesions, we compared outcomes of surgical and endovascular treatment.
METHODS
From May 2002 to April 2007, 27 limbs of 18 patients underwent bypass operation and 23 limbs of 21 patients underwent stent placement for TASC C & D iliac lesions at Dongsan Medical Center. Age, sex, risk factor, combined diseases, clinical symptoms, treatment method, and patency rate were reviewed retrospectively.
RESULTS
Technical and clinical success was achieved in all patients of the bypass group and in 95.8% of patients in the stent group. There were no complications in the surgical group, but 4 major complications in the stent group: 3 distal embolizations, and 1 arterial rupture. The primary patency rates at 6 months, 1, 2, and 3 years were all 90% in the bypass group and 95%, 89%, 89%, and 89%, respectively, in the stent group (P=0.99). The respective secondary patency rates were all 90% in the bypass group and 100%, 94%, 94%, and 94% in the stent group (P=0.56).
CONCLUSION
Arterial bypass and stent placement are technically safe and effective treatment modalities in TASC C & D lesions of the iliac artery. A liberal posture to open arterial reconstruction extends the ability to treat diffuse TASC C & D lesions via endovascular means.

Keyword

Aortoiliac artery; Trans-Atlantic Inter-Society Consensus; Endovascular stent; Bypass

MeSH Terms

Extremities
Humans
Iliac Artery
Posture
Retrospective Studies
Risk Factors
Rupture
Stents
Full Text Links
  • JKSVS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2025 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr